742
J. Am. Chem. Soc. 2000, 122, 742-743
Tyrosine Sulfation on a PSGL-1 Glycopeptide
Influences the Reactivity of Glycosyltransferases
Responsible for Synthesis of the Attached O-Glycan
Kathryn M. Koeller, Mark E. B. Smith, and Chi-Huey Wong*
Department of Chemistry, The Scripps Research Institute and
Skaggs Institute for Chemical Biology
10550 N. Torrey Pines Rd., La Jolla, California 92037
ReceiVed October 27, 1999
P-Selectin glycoprotein ligand-1 (PSGL-1) is the primary
counter-receptor for P-selectin during leukocyte extravasation in
the inflammatory response.1 Previously, it has been determined
that the O-glycan attached to threonine 16 and at least one site
of tyrosine sulfation within the N-terminal 19 amino acids are
required for optimal recognition of PSGL-1 by P-selectin.2 In fact,
the N-terminal glycosulfopeptide binds to P-selectin nearly as
efficiently as the full-length dimeric PSGL-1, and the sulfated
glycopeptide binds to the receptor approximately 105 times more
tightly than does the unsulfated glycopeptide ligand (Figure 1a).3
The O-linked glycan structure from PSGL-1 includes a terminal
sialyl Lewis x (sLex) tetrasaccharide extended from a core 2
glycan (Figure 1b).4
To further examine PSGL-1/P-selectin recognition, as well as
to investigate PSGL-1 biosynthesis, the chemoenzymatic synthesis
of a binding determinant of PSGL-1 was undertaken. The target
structure represents a minimal sequence containing a tyrosine
sulfate and the glycosylated threonine residue, corresponding to
amino acid residues 10-17 of the mature PSGL-1 protein. The
synthesis combined solution- and solid-phase methods to arrive
at a disaccharide-linked octapeptide in both sulfated and unsulfated
forms. Glycosyltransferase-catalyzed elaboration of the glycan was
then studied.5 Results indicate that sulfation on tyrosine influences
the reactivity of the glycosyltransferases responsible for the
synthesis of sLex on the attached O-glycan.
Figure 1. (a) The P-selectin/PSGL-1 interaction. (b) The N-terminal
structure of PSGL-1.
Scheme 1. Synthesis of the glyco-Thr Building Block
The synthetic strategy involved incorporation of a protected
disaccharide-linked threonine building block into solid-phase
peptide synthesis (Scheme 1). Disaccharide-threonine conjugate
3 was obtained by reaction of 16 with either glycosyl donor 2a7
under BF3-OEt2 catalysis or donor 2b8 with DMTST as the
activating agent.9 Conversion of 3 to 5 was accomplished by
standard synthetic manipulations.
Building block 5 was incorporated into glycopeptide 6 utilizing
a Rink Amide modified resin as the solid phase (Scheme 2).
Following N-terminal acetylation, sequence 6 was treated with
95% TFA, H2O, and ethane dithiol as a scavenger. These
conditions caused simultaneous liberation of the sequence from
the resin as the C-terminal amide and removal of the tBu ester
a Conditions: (a) BF3-OEt2, -30 ˚C, CH2Cl2 (100%); (b) DMTST,
CH2Cl2, 4 Å MS, 0 ˚C (75%); (c) AcOH/H2O, 45 ˚C; (d) Ac2O/Pyr; (e)
Zn dust, THF/AcOH/Ac2O (80%, 3 steps); (f) TFA/H2O (95:5) (100%).
and ether protecting groups. The crude peptide obtained was
initially purified by ether precipitation and small portions then
further purified using RP-HPLC to give sequence 7.10
Sulfation on the tyrosine residue of glycopeptide 7 was then
accomplished with sulfur trioxide-pyridine complex. A workup
protocol involving a methanol quench and immediate silica gel
chromatography11 allowed the sulfated sequence to be isolated
in much higher yields than has been previously reported.12
Saponification of the acetate esters then gave deprotected gly-
copeptide 8a for the subsequent glycosyltransferase-catalyzed
(1) (a) Kansas, G. S. Blood 1996, 88, 3259. (b) Rosen, S. D.; Bertozzi, C.
R. Curr. Biol. 1996, 6, 261.
(2) (a) Wilkins, P. P.; Moore, K. L.; McEver, R. P.; Cummings, R. D. J.
Biol. Chem. 1995, 270, 22677. (b) DeLuca, M.; Dunlop, L. C.; Andrews, R
K.; Flannery, J. V., Jr.; Ettling, R.; Cumming, D. A.; Veldman, G. M.; Berndt,
M. C. J. Biol. Chem. 1995, 270, 26734. (c) Sako, D.; Comess, K. M.; Barone,
K. M.; Camphausen, R. T.; Cumming, D. A.; Shaw, G. D. Cell 1995, 83,
323. (d) Pouyani, T.; Seed, B. Cell 1995, 83, 333.
(3) Leppanen, A.; Mehta, P.; Ouyang, Y.-B.; Ju, T.; Helin, J.; Moore, K.
L.; van Die, I.; Canfield, W. M.; McEver, R. P.; Cummings, R. D. J. Biol.
Chem. 1999, 274, 24838.
(4) Wilkins, P. P.; McEver, R. P.; Cummings, R. D. J. Biol. Chem. 1996,
271, 18732.
(5) For a previous chemoenzymatic approach to glycopeptide synthesis,
see: Seitz, O.; Wong C.-H. J. Am. Chem. Soc. 1997, 119, 8766.
(6) Mathieux, N.; Paulsen, H.; Meldal, M.; Bock, K. J. Chem. Soc., Perkin
Trans. 1 1997, 2359.
(7) Dullenkopf, W.; Castro-Palomino, J. C.; Manzoni, L.; Schmidt, R. R.
Carbohydr. Res. 1996, 296, 135.
(10) Initial attempts to employ commercially available Fmoc-Tyr(OSO3-)-
OH in SPPS to give the sulfated glycopeptide were unsuccessful. Problems
arose when attempts to remove tBu groups in the presence of the sulfate
failed: (a) Yagami, T.; Shiwa, S.; Futaki, S.; Kitagawa, K. Chem. Pharm.
Bull. 1993, 41, 376. (b) Kitagawa, K.; Futaki, S.; Yagami, T.; Sumi, S.; Inoue,
K. Int. J. Peptide Protein Res. 1994, 43, 190.
(11) The workup procedure employed was previously used for the sulfation
of carbohydrate hydroxyls: Sanders, W. J.; Manning, D. D.; Koeller, K. M.;
Kiessling, L. L. Tetrahedron 1997, 53, 16391.
(12) Marseigne, I.; Roy, P.; Dor, A.; Durieuz, C.; Pelaprat, D.; Reibaud,
M.; Blanchard, J. C.; Roques, B. P. J. Med. Chem. 1989, 32, 445.
(8) Schulz, M.; Kunz, H. Tetrahedron Asymm. 1993, 4, 1205.
(9) Zhang, Z.; Ollmann, I. R.; Ye, X.-S.; Wischnat, R.; Baasov, T.; Wong,
C.-H. J. Am. Chem. Soc. 1999, 121, 734.
10.1021/ja993820o CCC: $19.00 © 2000 American Chemical Society
Published on Web 01/19/2000